|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▼
|
Registration date ▲
|
Status ▲
|
|
DROSPIRENONE AND ESTETROL |
G03AA18 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005336 |
19-05-2021 |
VALID
|
|
VERICIGUAT |
C01DX22 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005319 |
16-07-2021 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
EPTINEZUMAB |
N02CD05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005287 |
24-01-2022 |
VALID
|
|
TECOVIRIMAT |
J05AX24 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005248 |
06-01-2022 |
VALID
|
|
AVAPRITINIB |
L01EX18 |
DE
|
POM
|
18-01-2021 |
EMEA/H/C/005208 |
24-09-2020 |
VALID
|
|
DOSTARLIMAB |
L01FF07 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005204 |
21-04-2021 |
VALID
|
|
FINERENONE |
C03DA05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005200 |
16-02-2022 |
VALID
|
|
TIRBANIBULIN |
D06BX03 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005183 |
16-07-2021 |
VALID
|
|
SACITUZUMAB GOVITECAN |
L01FX17 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005182 |
22-11-2021 |
VALID
|
|
PONESIMOD |
L04AE04 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005163 |
19-05-2021 |
VALID
|
|
DENGUE VIRUS VACCINES |
J07BX04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005155 |
05-12-2022 |
VALID
|
|
IODINE IOFLUPANE (123I) |
V09AB03 |
DE
|
POM
|
|
EMEA/H/C/005135 |
17-06-2021 |
VALID
|
|
MIRIKIZUMAB |
L04AC24 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005122 |
26-05-2023 |
VALID
|
|
FILGOTINIB |
L04AF04 |
DE
|
POM
|
18-01-2021 |
EMEA/H/C/005113 |
24-09-2020 |
VALID
|
|
LATANOPROST AND NETARSUDIL |
S01EE51 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005107 |
07-01-2021 |
VALID
|
|
SETMELANOTIDE |
A08AA12 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005089 |
16-07-2021 |
VALID
|
|
LUMASIRAN |
A16AX18 |
DE
|
POM
|
18-01-2021 |
EMEA/H/C/005040 |
19-11-2020 |
VALID
|
|
TAGRAXOFUSP |
L01XX67 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005031 |
07-01-2021 |
VALID
|
|
FEDRATINIB |
L01XE57 |
DE
|
POM
|
02-06-2021 |
EMEA/H/C/005026 |
08-02-2021 |
VALID
|
|
ULIPRISTAL |
G03XB02 |
DE
|
POM
|
12-11-2018 |
EMEA/H/C/005017 |
09-02-2018 |
VALID
|
|
FOSTEMSAVIR |
J05AX29 |
DE
|
POM
|
02-06-2021 |
EMEA/H/C/005011 |
04-02-2021 |
VALID
|
|
ZANUBRUTINIB |
L01EL03 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/004978 |
22-11-2021 |
VALID
|
|
ISATUXIMAB |
L01FC02 |
DE
|
POM
|
22-12-2020 |
EMEA/H/C/004977 |
30-05-2020 |
VALID
|
|
ANIFROLUMAB |
L04AG11 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/004975 |
14-02-2022 |
VALID
|
|
TEBENTAFUSP |
L01XX75 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/004929 |
01-04-2022 |
VALID
|
|
BROLUCIZUMAB |
S01LA06 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004913 |
13-02-2020 |
VALID
|
|
LAMIVUDINE AND DOLUTEGRAVIR |
J05AR25 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004909 |
30-06-2019 |
VALID
|
|
SOLRIAMFETOL |
N06BA14 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004893 |
16-01-2020 |
VALID
|
|
ROXADUSTAT |
B03XA05 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/004871 |
18-08-2021 |
VALID
|
|
POLATUZUMAB VEDOTIN |
L01FX14 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004870 |
16-01-2020 |
VALID
|
|
VOXELOTOR |
B06AX03 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/004869 |
14-02-2022 |
VALID
|
|
DELAFLOXACIN |
J01MA23 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004860 |
16-12-2019 |
VALID
|
|
BULEVIRTIDE |
J05AX28 |
DE
|
POM
|
22-12-2020 |
EMEA/H/C/004854 |
31-07-2020 |
VALID
|
|
OLIPUDASE ALFA |
A16AB25 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/004850 |
24-06-2022 |
VALID
|
|
CAPMATINIB |
L01EX17 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/004845 |
20-06-2022 |
VALID
|
|
CEMIPLIMAB |
L01FF06 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004844 |
27-06-2019 |
VALID
|
|
FREMANEZUMAB |
N02CD03 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004833 |
27-03-2019 |
VALID
|
|
CEFIDEROCOL |
J01DI04 |
DE
|
POM
|
22-12-2020 |
EMEA/H/C/004829 |
23-04-2020 |
VALID
|
|
ETRANACOGENE DEZAPARVOVEC |
B06XX00 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/004827 |
20-02-2023 |
VALID
|
|
OSILODROSTAT |
H02CA02 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004821 |
09-01-2020 |
VALID
|
|
INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN |
J07BB02 |
DE
|
POM
|
21-10-2019 |
EMEA/H/C/004814 |
12-12-2018 |
VALID
|
|
IMIPENEM, CILASTATIN AND RELEBACTAM |
J01DH56 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004808 |
13-02-2020 |
VALID
|
|
LANADELUMAB |
B06AC05 |
DE
|
POM
|
21-10-2019 |
EMEA/H/C/004806 |
22-11-2018 |
VALID
|
|
DAROLUTAMIDE |
L02BB06 |
DE
|
POM
|
22-11-2023 |
EMEA/H/C/004790 |
27-03-2020 |
VALID
|
|
SATRALIZUMAB |
L04AC19 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/004788 |
24-06-2021 |
VALID
|
|
FIDANACOGENE ELAPARVOVEC |
B02BD17 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/004774 |
24-07-2024 |
VALID
|
|
DURVALUMAB |
L01FF03 |
DE
|
POM
|
12-11-2018 |
EMEA/H/C/004771 |
20-09-2018 |
VALID
|
|
GILTERITINIB |
L01EX13 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004752 |
24-10-2019 |
VALID
|
|
DORAVIRINE |
J05AG06 |
DE
|
POM
|
21-10-2019 |
EMEA/H/C/004747 |
22-11-2018 |
VALID
|
